Jinshiya Medicine: Director Zheng Zhiyong intends to reduce 0.19% of his holdings.

Jinshiya Pharmaceuticals announced that the company's director, Zheng Zhiyong, holds 3.4653 million shares, accounting for 0.86% of the total share capital. Due to his own funding needs, he plans to reduce his holdings by no more than 776,300 shares, or 0.19% of the total share capital, through centralized bidding or block trading within three months after the disclosure of this announcement, starting from 15 trading days later. The source of the planned reduction of shares is the shares issued for the purchase of assets and the shares transferred from profit distribution.